Immunization, measles second dose in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Immunization, measles second dose was 94.0% in 2024. ▲ Rising
Immunization, measles second dose in Europe & Central Asia (excluding high income), 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
In 2024, immunization, measles second dose in Europe & Central Asia (excluding high income) stood at 94.0%.
That represents a change of down 0.9% on the previous year and up 5.6% over ten years.
Over the whole period, immunization, measles second dose in Europe & Central Asia (excluding high income) peaked at 95.8% in 2004 and was at its lowest, 49.7%, in 2000.
Europe & Central Asia (excluding high income) ranks 1st of 43 groups on this measure, in the top 10%.
The long-run direction has been consistently rising across the 25 years of available data.
Immunization, measles second dose in Europe & Central Asia (excluding high income), year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 49.7% | — |
| 2001 | 88.9% | +78.8% |
| 2002 | 88.4% | -0.6% |
| 2003 | 95.2% | +7.8% |
| 2004 | 95.8% | +0.6% |
| 2005 | 93.3% | -2.6% |
| 2006 | 85.5% | -8.4% |
| 2007 | 86.5% | +1.2% |
| 2008 | 83.0% | -4.1% |
| 2009 | 75.1% | -9.5% |
| 2010 | 80.1% | +6.7% |
| 2011 | 87.8% | +9.5% |
| 2012 | 87.3% | -0.5% |
| 2013 | 91.8% | +5.2% |
| 2014 | 89.1% | -3.0% |
| 2015 | 88.1% | -1.1% |
| 2016 | 85.2% | -3.3% |
| 2017 | 92.0% | +8.0% |
| 2018 | 92.9% | +1.0% |
| 2019 | 93.6% | +0.7% |
| 2020 | 92.2% | -1.4% |
| 2021 | 93.6% | +1.5% |
| 2022 | 93.0% | -0.6% |
| 2023 | 94.9% | +2.0% |
| 2024 | 94.0% | -0.9% |
Biggest year-on-year movements
Years where Immunization, measles second dose in Europe & Central Asia (excluding high income) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2001 | +78.8% | 49.7% | 88.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 84.2% | 49.7% | 95.8% | 10 |
| 2010s | 88.8% | 80.1% | 93.6% | 10 |
| 2020s | 93.6% | 92.2% | 94.9% | 5 |
Countries ranked near Europe & Central Asia (excluding high income)
- 1 Bahrain 99.0% compare
- 1 Brunei 99.0% compare
- 1 Cuba 99.0% compare
- 1 Hungary 99.0% compare
- 1 Iran 99.0% compare
- 1 North Korea 99.0% compare
- 1 Maldives 99.0% compare
- 1 Nauru 99.0% compare
- 1 Oman 99.0% compare
- 1 Qatar 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
- 1 Turkmenistan 99.0% compare
- 1 Uzbekistan 99.0% compare
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is immunization, measles second dose in Europe & Central Asia (excluding high income)?
- Immunization, measles second dose in Europe & Central Asia (excluding high income) was 94.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 95.8% in 2004.
- What is the lowest immunization, measles second dose recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 49.7% in 2000.
- How does Europe & Central Asia (excluding high income) rank for immunization, measles second dose?
- Europe & Central Asia (excluding high income) ranks 1st out of 43 groups with data for 2024.
- Is immunization, measles second dose rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is up 5.6%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.